GATA1 and neoplasm: Kaplan-Meier survival analysis demonstrated that patients with high GATA1 expression exhibited significantly worse relapse-free survival compared to those with low GATA1 expression (Fig. S4C, D), reinforcing the role of GATA1 in tumor progression.